Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Renal Cell Metastasis”

1,232 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,232 results

Not applicableStudy completedNCT06607809
What this trial is testing

Inflammatory Markers (ICC, MCVL) and Nivolumab Response: Predicting Immunotherapy Success in Metastatic RCC

Who this might be right for
Metastatic Renal Cell Carcinoma
Dr. Lutfi Kirdar Kartal Training and Research Hospital 99
Early research (Phase 1)Looking for participantsNCT06479811
What this trial is testing

[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

Who this might be right for
Head and Neck TumorsKidney CancersSmall Cell Lung Cancers+3 more
National Cancer Institute (NCI) 120
Large-scale testing (Phase 3)Study completedNCT02231749
What this trial is testing

Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214)

Who this might be right for
Advanced Renal Cell CarcinomaMetastatic Renal Cell Carcinoma
Bristol-Myers Squibb 1,390
Testing effectiveness (Phase 2)Study completedNCT00923845
What this trial is testing

Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer

Who this might be right for
Renal Cell CarcinomaGraft-Versus-Host DiseaseEngraftment Syndrome
National Cancer Institute (NCI) 25
Early research (Phase 1)Study completedNCT02264548
What this trial is testing

A Phase I Evaluating Integration of HypofractionatedStudy Renal Ablative Radiotherapy

Who this might be right for
Renal Cell Carcinoma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 14
Not applicableStudy completedNCT01773655
What this trial is testing

Clinical and Histopathologic Characteristics of BAP1 Mutations

Who this might be right for
Malignant Pleural Mesothelioma (MPM)Choroidal NevusPrimary Uveal Melanoma (UM)+3 more
Memorial Sloan Kettering Cancer Center 196
Testing effectiveness (Phase 2)Active Not RecruitingNCT05012371
What this trial is testing

Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more
M.D. Anderson Cancer Center 90
Not applicableLooking for participantsNCT06327178
What this trial is testing

Systemic Anti-tumor Activity and Safety of the Combination of SBRT and Concurrent PD-1 Blockade in Metastatic RCC.

Who this might be right for
Systemic Anti-tumor Activity and Safety of the Combination of SBRT and Concurrent PD-1 Blockade in Metastatic RCC
Nanfang Hospital, Southern Medical University 20
Not applicableStudy completedNCT02944617
What this trial is testing

Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor

Who this might be right for
DiarrheaMetastatic Renal Cell CarcinomaStage IV Renal Cell Cancer
City of Hope Medical Center 21
Testing effectiveness (Phase 2)UnknownNCT03961698
What this trial is testing

Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma

Who this might be right for
Breast CancerRenal Cell Carcinoma
Infinity Pharmaceuticals, Inc. 91
Testing effectiveness (Phase 2)Ended earlyNCT00429026
What this trial is testing

Conditioning Regimen in Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Renal Cell Cancer
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00663559
What this trial is testing

Sunitinib in Patients With Renal Cells Carcinoma Metastasic or Locally Avanced in Patients Not Candidates to Curative Previous Nefrectomy

Who this might be right for
Carcinoma Renal Cells
Spanish Oncology Genito-Urinary Group 59
Testing effectiveness (Phase 2)Study completedNCT00515697
What this trial is testing

Ramucirumab in Participants With Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Eli Lilly and Company 39
Early research (Phase 1)Study completedNCT00036959
What this trial is testing

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more
National Institutes of Health Clinical Center (CC) 90
Post-approval studies (Phase 4)Ended earlyNCT02570789
What this trial is testing

Evaluation of Predictive Markers for Toxicity and Efficacy in Patients With mccRCC Treated by Anti-VEGF Therapy

Who this might be right for
Clear-cell Metastatic Renal Cell Carcinoma
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 90
Large-scale testing (Phase 3)Active Not RecruitingNCT05043090
What this trial is testing

Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC

Who this might be right for
Papillary Renal Cell Carcinoma
AstraZeneca 148
Not applicableUnknownNCT01230697
What this trial is testing

Perspective Evaluation of Hormones Involved in Serum Phosphate Homeostasis in Patients With Metastatic Renal Cells Carcinoma or Hepatocellular Carcinoma Treated With Sorafenib (SORHORM)

Who this might be right for
Kidney CancerLiver Cancer
University of Turin, Italy 60
Early research (Phase 1)Study completedNCT00694096
What this trial is testing

Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response

Who this might be right for
Renal Cell Cancer
University of Utah 25
Testing effectiveness (Phase 2)Study completedNCT01524926
What this trial is testing

CREATE: Cross-tumoral Phase 2 With Crizotinib

Who this might be right for
Locally Advanced and/or Metastatic Anaplastic Large Cell LymphomaLocally Advanced and/or Metastatic Inflammatory Myofibroblastic TumorLocally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1+3 more
European Organisation for Research and Treatment of Cancer - EORTC 582
Testing effectiveness (Phase 2)Study completedNCT00226980
What this trial is testing

A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma

Who this might be right for
Kidney Neoplasms
Stanford University 30
Load More Results